Fused pyrazine derivatives as A2A/A2B inhibitors
X Wang, Y Li, C Qi, L Wu, W Yao, W Zhu - US Patent 11,161,850, 2021 - Google Patents
2019-07-23 Assigned to INCYTE CORPORATION reassignment INCYTE CORPORATION
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Fused pyrimidine derivatives as A2A/A2B inhibitors
X Wang, H Han, MS McCammant, L Wu… - US Patent …, 2021 - Google Patents
8,288,536 B2 8,349,850 B2 8,431,596 B2 8,569,300 B2 8,575,183 B2 8,580,812 B2
8,637,542 B2 8,865,731 B2 8,865,734 B2 9,029,389 B2 9,029,393 B2 9,034,872 B2 …
8,637,542 B2 8,865,731 B2 8,865,734 B2 9,029,389 B2 9,029,393 B2 9,034,872 B2 …
Imidazopyrimidines and triazolopyrimidines as a2a/a2b inhibitors
X Wang, P Gan, T Huang, C Qi, DQ Qian, L Wu… - US Patent …, 2023 - Google Patents
2022-05-12 Assigned to INCYTE CORPORATION reassignment INCYTE CORPORATION
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Pyrazolopyridines and triazolopyridines as A2A/A2B inhibitors
T Huang, X Wang - US Patent 11,390,624, 2022 - Google Patents
6,545,000 B1 6,921,762 B2 7,041,666 B2 7,306,631 B2 7,452,892 B2 7,501,411 B2
7,511,050 B2 7,563,788 B2 7,674,791 B2 7,700,594 B2 7,709,468 B2 7,834,014 B2 …
7,511,050 B2 7,563,788 B2 7,674,791 B2 7,700,594 B2 7,709,468 B2 7,834,014 B2 …
1, 8-naphthyridinone compounds and uses thereof
SM Pham, J Chen, A Ansari, PS Jadhavar… - US Patent …, 2020 - Google Patents
naphthyridinone compounds as modulators of an adenosine receptor are provided. The
compounds may find use as therapeutic agents for the treatment of diseases mediated …
compounds may find use as therapeutic agents for the treatment of diseases mediated …
Heterocyclic compounds as adenosine antagonists
SM Pham, J Chen, A Ansari, PS Jadhavar… - US Patent …, 2021 - Google Patents
Aminopyrazine compounds as modulators of an adenosine receptor are provided. The
compounds may find use as therapeutic agents for the treatment of diseases mediated …
compounds may find use as therapeutic agents for the treatment of diseases mediated …
Pyrazolopyridines and triazolopyridines as A2A/A2B inhibitors
T Huang, X Wang - US Patent 11,884,665, 2024 - Google Patents
MSXIFXOIITVIOS-UHFFFAOYSA-N 3-[4-amino-2-[(3-fluoropyridin-2-yl) methyl]-7-pyrimidin-4-
yltriazolo [4, 5-c] pyridin-6-yl] benzonitrile Chemical compound NC1= NC (= C (C= 2C1= NN …
yltriazolo [4, 5-c] pyridin-6-yl] benzonitrile Chemical compound NC1= NC (= C (C= 2C1= NN …
Fused pyrazine derivatives as A2A/A2B inhibitors
2023-07-19 Assigned to INCYTE CORPORATION reassignment INCYTE CORPORATION
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Fused pyrimidine derivatives as A2A/A2B inhibitors
X Wang, H Han, MS McCammant, L Wu… - US Patent …, 2024 - Google Patents
2021-02-09 Assigned to INCYTE CORPORATION reassignment INCYTE CORPORATION
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Anti-CD73 antibodies and uses thereof
HG Nastri, SM Stewart, JC Almagro, J Zhou… - US Patent …, 2024 - Google Patents
US12018089B2 - Anti-CD73 antibodies and uses thereof - Google Patents US12018089B2 -
Anti-CD73 antibodies and uses thereof - Google Patents Anti-CD73 antibodies and uses …
Anti-CD73 antibodies and uses thereof - Google Patents Anti-CD73 antibodies and uses …